Drug Trial Radar · NCT06818968
A Study of the Effect of Multiple Doses of Diltiazem on the Plasma Levels of MK-6916 in Healthy Participants (MK-6916-005)
Last checked: Nov 19, 2026Latest source record: Aug 26, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
37
Actual
Start
Feb 27, 2025
Primary completion
Aug 8, 2025
Study completion Aug 8, 2025
Sponsor
- Lead sponsor
- Merck Sharp & Dohme LLCMerck & Co. (MRK)
- Sponsor type
- Industry
- First posted
- Feb 11, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Basic science
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 55 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The goal of the study is to learn what happens to levels of MK-6916 in a healthy person's body over time. Researchers will compare what happens to MK-6916 in the body when it is given with or without another medicine called diltiazem.
Conditions
- Healthy
Interventions
MK-6916Drug
Oral administration
DiltiazemDrug
Oral administration
Primary outcomes
What the sponsor says the trial is designed to measure.
- Area Under the Concentration-Time Curve from Time 0 to Infinity (AUC0-Inf) of MK-6916Time frame: Predose and at designated time points (up to 8 weeks)
- Area Under the Concentration-Time Curve from Time 0 to 24 hours (AUC0-24hrs) of MK-6916Time frame: Predose and at designated time points (up to 24 hours)
- Plasma Concentration at 24 Hours (C24) of MK-6916Time frame: Predose and at designated time points (up to 24 hours)
- Plasma Concentration at 12 Hours (C12) of MK-6916Time frame: Predose and at designated time points (up to 12 hours)
- Maximum Plasma Concentration (Cmax) of MK-6916Time frame: Predose and at designated time points (up to 8 weeks)
- Time to Maximum Plasma Concentration (Tmax) of MK-6916Time frame: Predose and at designated time points (up to 8 weeks)
- Apparent Clearance (CL/F) of MK-6916Time frame: Predose and at designated time points (up to 8 weeks)
- Apparent Volume of Distribution (Vz/F) of MK-6916Time frame: Predose and at designated time points (up to 8 weeks)
- Apparent Terminal Half-life (t1/2) of MK-6916Time frame: Predose and at designated time points (up to 8 weeks)
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Fortrea CRU, Madison ( Site 0001)
Madison, Wisconsin
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.